Philip Morris International and others agree to pay $23.6 billion

Oct.21.2024
Philip Morris International and others agree to pay $23.6 billion
Philip Morris International, British American Tobacco, and Japan Tobacco agree to pay $236 billion to resolve long-standing Canadian tobacco litigation.

According to a recent report by Reuters, Philip Morris International (PMI), British American Tobacco, and Japan Tobacco have agreed to pay 32.5 billion Canadian dollars (23.6 billion US dollars) to settle long-standing tobacco litigation in Canada. This is part of a plan proposed by a court-appointed mediator.


Jacob Shelley, co-director of the Western Canada University Laboratory for Ethics, Law, and Health Policy, stated that if the plan is accepted, this would be the largest settlement agreement in a similar case outside the United States.


According to reports, in 2015, subsidiaries of the three largest tobacco companies in Canada suffered a major blow in Quebec. A court ruled for them to compensate around 100,000 smokers or former smokers, as they claimed the companies knew since the 1950s that their products could cause cancer and other illnesses, but failed to warn consumers.


After an appeal, the Quebec Court upheld the 2015 ruling requiring tobacco companies to pay over $15.5 billion Canadian dollars in compensation to smokers. This has forced the subsidiaries of the three major tobacco manufacturers to seek bankruptcy protection. Canadian Tobacco Company is required to pay the largest amount of compensation, totaling $10.5 billion Canadian dollars. Philip Morris is obligated to pay $3.1 billion Canadian dollars, while Japan Tobacco's compensation amount is $2 billion Canadian dollars. The case is expected to be appealed to the Supreme Court of Canada.


Afterwards, the three companies entered into court-supervised mediation to discuss possible settlement agreements. It has been reported that the distribution of the total amount of the agreement remains unresolved.


Despite some important issues still to be resolved in the planned legal process, we hope that this will be concluded quickly, allowing RBH (Rothmans, Benson & Hedges) and stakeholders to focus on the future," said Jacek Olczak, CEO of Philip Morris International (PMI), on Friday. Rothmans, Benson & Hedges is a Canadian subsidiary of Philip Morris International (PMI).


On Friday, British American Tobacco announced that the proposed plan represents a step towards finding a solution. The company did not provide details of the plan like Philip Morris International (PMI) did. The company stated that its subsidiary, Imperial Tobacco Canada, supports the framework and structure of the plan, and the settlement will be funded by existing funds and future funds from the sale of tobacco products in Canada.


Philip Morris International (PMI) has stated that the plaintiffs (smokers) will decide by December 2024 whether to accept the plan, with judicial approval expected in the first half of the following year. A subsidiary of Japan Tobacco, JTI-Macdonald, has stated, "To find a viable solution, key issues must be addressed," but did not provide further details.


Jacob Shelley of Western Canada University believes that the settlement agreement missed an opportunity to incorporate company policy terms, but emphasizes the responsibility of manufacturers to warn consumers of the risks of their products. This could have implications for industries such as alcohol. He added, "We have not given sufficient warnings about the risks of many products. Manufacturers have a duty to alert us to these risks... Hopefully this will change manufacturers' views on potential liability.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | BAT Japan Launches virto Bright Peach Click in Japan, Expanding glo Hilo’s Capsule-Based Flavor Portfolio
Product | BAT Japan Launches virto Bright Peach Click in Japan, Expanding glo Hilo’s Capsule-Based Flavor Portfolio
British American Tobacco Japan (BAT Japan) has introduced virto Bright Peach Click, a new heated tobacco stick designed for the glo Hilo system. The product expands the existing virto consumable lineup with a combination of tobacco, menthol and ripe peach flavors, featuring a capsule mechanism that releases additional fruit flavor when activated. The product launched in Japan on July 27, 2026, through glo official online channels, convenience stores and tobacco retailers.
Aug.03
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Gallup Tracks Nicotine Pouch Use for the First Time: 11% of U.S. Adults Smoke, 9% Vape and 4% Use Nicotine Pouches
Gallup Tracks Nicotine Pouch Use for the First Time: 11% of U.S. Adults Smoke, 9% Vape and 4% Use Nicotine Pouches
Gallup’s 2026 Consumption Habits survey tracked nicotine pouch use for the first time. The survey found that 11% of U.S. adults reported smoking cigarettes in the past week, 9% reported vaping, and 4% reported using nicotine pouches. Cigarette smoking remained near Gallup’s long-term low, while adult vaping rates stayed relatively stable in recent years.
Market
Aug.25 by 2Firsts Perspectives
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
Chinese authorities have disclosed the country’s first reported criminal case involving counterfeit vapes marketed as “medical nebulizers” and “zero-nicotine” products. Authorities determined that the products involved were counterfeit vapes and pursued criminal charges for producing and selling counterfeit goods. According to the report, the case resulted in the seizure of 347,000 counterfeit vape pods and 53,700 vape devices, with physical goods valued at 22.13 million yuan.
Aug.04
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
Bret Koplow, acting director of the U.S. Food and Drug Administration's Center for Tobacco Products, will deliver a keynote and participate in a fireside chat at the National Association of Tobacco Outlets' Sept. 29-30 conference in Washington. His appearance comes months after the FDA moved to accelerate PMTA reviews and introduced a more differentiated enforcement policy for certain unauthorized ENDS and oral nicotine pouch products. The agency also plans a public list identifying manufacturers and products it does not currently intend to prioritize for enforcement under the May guidance. NATO says its membership includes more than 66,000 retail stores, making product-status transparency and enforcement boundaries directly relevant to the retail sector.
Aug.14
UK Reform Party Proposes Cap of 1,000 Vape Shops Under Plan to Tighten Retail Controls
UK Reform Party Proposes Cap of 1,000 Vape Shops Under Plan to Tighten Retail Controls
The UK Reform Party has proposed limiting the number of dedicated vape shops in the country to around 1,000 as part of a plan to tighten oversight of vape retail channels. The proposal was put forward by Reform UK deputy leader and MP Lee Anderson. The plan remains a political proposal and has not become UK government policy, with no detailed legislation, implementation timeline or allocation rules announced.
Aug.10